Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood

Clinical Biochemistry

Volumn 40, Issue 1-2, 2007, Pages 111-118

  Rissanen, Maria ^a   Helo, Pauliina ^a,b   Väänänen, Riina Minna ^a   Wahlroos, Veikko ^a   Lilja, Hans ^b,c   Nurmi, Martti ^a   Pettersson, Kim ^a   Nurmi, Jussi ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Neoplasm circulating cells; Reproducibility of results; Reverse transcriptase polymerase chain reaction; Sensitivity and specificity; Tissue kallikreins

Indexed keywords

CHELATE; LANTHANIDE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; CALCULATION; CELL STRAIN LNCAP; CONTROLLED STUDY; FLUOROMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; VALIDATION STUDY;

FALSE POSITIVE REACTIONS; FEMALE; FLUOROMETRY; GENE DOSAGE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE KALLIKREINS; TUMOR CELLS, CULTURED;

EID: 33845764381     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.10.005     Document Type: Article

References (26)

1. Mattano Jr. L.A., Moss T.J., and Emerson S.G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 52 (1992) 4701-4705
2. Moreno J.G., Croce C.M., Fischer R., Monne M., Vihko P., Mulholland S.G., et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 52 (1992) 6110-6112
3. Nashed A.L., Rao K.W., and Gulley M.L. Clinical applications of BCR-ABL molecular testing in acute leukemia. J. Mol. Diagn. 5 (2003) 63-72
4. Shariat S.F., Gottenger E., Nguyen C., Song W., Kattan M.W., Andenoro J., et al. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Cancer Res. 62 (2002) 5974-5979
5. Patel K., Whelan P.J., Prescott S., Brownhill S.C., Johnston C.F., Selby P.J., et al. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer. Clin Cancer Res. 10 (2004) 7511-7519
6. Smith M.R., Biggar S., and Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res. 55 (1995) 2640-2644
7. Stahlberg A., Hakansson J., Xian X., Semb H., and Kubista M. Properties of the reverse transcription reaction in mRNA quantification. Clin. Chem. 50 (2004) 509-515
8. Huggett J., Dheda K., Bustin S., and Zumla A. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6 (2005) 279-284
9. Bustin S.A., and Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. 15 (2004) 155-166
10. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29 (2002) 23-39
11. Slawin K.M., Shariat S.F., Nguyen C., Leventis A.K., Song W., Kattan M.W., et al. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. Cancer Res. 60 24 (2000) 7142-7148
12. Heuze-Vourc'h N., Leblond V., and Courty Y. Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen). Eur. J. Biochem. 270 4 (2003) 706-714
13. Ylikoski A., Sjoroos M., Lundwall A., Karp M., Lovgren T., Lilja H., et al. Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA. Clin. Chem. 45 (1999) 1397-1407
14. Nurmi J., Lilja H., and Ylikoski A. Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids. Luminescence 15 (2000) 381-388
15. Emmanouilidou E., Ioannou P.C., Christopoulos T.K., and Polizois K. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format. Anal. Biochem. 313 (2003) 97-105
16. Lintula S., Vesalainen S., Rannikko A., Zhang W.M., Finne P., Stenman J., et al. Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand. J. Clin. Lab. Invest. 64 (2004) 93-100
17. Becker-Andre M., and Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res. 17 (1989) 9437-9446
18. Chelly J., Montarras D., Pinset C., Berwald-Netter Y., Kaplan J.C., and Kahn A. Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells. Eur. J. Biochem. 187 (1990) 691-698
19. Ylikoski A., Karp M., Pettersson K., Lilja H., and Lovgren T. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients. J. Mol. Diagn. 3 (2001) 111-122
20. Nurmi J., Ylikoski A., Soukka T., Karp M., and Lovgren T. A new label technology for the detection of specific polymerase chain reaction products in a closed tube. Nucleic Acids Res. 28 (2000) E28
21. Hemmila I., and Laitala V. Progress in lanthanides as luminescent probes. J. Fluoresc. 15 (2005) 529-542
22. Nurmi J., Wikman T., Karp M., and Lovgren T. High-performance real-time quantitative RT-PCR using lanthanide probes and a dual-temperature hybridization assay. Anal. Chem. 74 (2002) 3525-3532
23. Hessels D., Klein Gunnewiek J.M., van Oort I., Karthaus H.F., van Leenders G.J., van Balken B., et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol. 44 (2003) 8-15
24. Lundwall A., and Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214 (1987) 317-322
25. Higuchi R., Fockler C., Dollinger G., and Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 11 (1993) 1026-1030
26. Wang Z.P., Eisenberger M.A., Carducci M.A., Partin A.W., Scher H.I., and Ts'o P.O. Identification and characterization of circulating prostate carcinoma cells. Cancer 88 (2000) 2787-2795